Deferasirox 68462-0494

Product NDC

68462-0494

Manufacturer: Glenmark Pharmaceuticals Inc., Usa
Dosage Form: Tablet, For Suspension
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: January 6, 2020
Listing Expires: December 31, 2026
Application: ANDA209433

Need to source Deferasirox? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Deferasirox	125 mg/1

Drug Class

Iron Chelator [EPC]Cytochrome P450 1A2 Inhibitors [MoA]Cytochrome P450 2C8 Inhibitors [MoA]

Packaging Options(1)

68462-0494-90

90 TABLET, FOR SUSPENSION in 1 BOTTLE (68462-494-90)

View →